tm logo

Monitor this mark

View On USPTO

NEXAVAR
Live/Registered
REGISTERED AND RENEWED

on 13 Jan 2024

Last Applicant/ Owned by

Bayer Aktiengesellschaft

Kaiser-Wilhelm-Allee, 1

Leverkusen

DE

51373

Serial Number

75943985 filed on 14th Mar 2000

Registration Number

2745627 registered on 05th Aug 2003

in the Principal Register

Correspondent Address

Sondra Schol

Sondra Schol

800 North Lindbergh Blvd., E2NA

St. Louis,MO 63167

Filing Basis

1. intent to use

Disclaimer

NO DATA

NEXAVAR

pharmaceutical preparations for the treatment of [ cardiovascular diseases, central nervous system diseases, ] cancer [, respiratory and infectious diseases, diagnostics reagents adapted for medical use ]

Classification Information

Class [005]
Pharmaceutical Products

pharmaceutical preparations for the treatment of [ cardiovascular diseases, central nervous system diseases, ] cancer [, respiratory and infectious diseases, diagnostics reagents adapted for medical use ]

Specimens

NEXAVAR specimenNEXAVAR specimenNEXAVAR specimenNEXAVAR specimenNEXAVAR specimenNEXAVAR specimenNEXAVAR specimenNEXAVAR specimenNEXAVAR specimenNEXAVAR specimen

Mark Details

Serial Number

No 75943985

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
13th Jan 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13th Jan 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
13th Jan 2024REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
13th Jan 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
17th Jul 2023TEAS SECTION 8 & 9 RECEIVED
05th Aug 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
16th Feb 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16th Feb 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14th Aug 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
14th Aug 2013REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED